Cholinesterase inhibitor rivastigmine enhance the mitochondrial electron transport chain in lymphocytes of patients with Alzheimer's disease

被引：26
|
作者：
Casademont, J
Miró, O
Rodriguez-Santiago, B
Viedma, P
Blesa, R
Cardellach, F
机构：
[1] Univ Barcelona, Fac Med, IDIBAPS, Hosp Clin,Internal Med Dept,Muscle Res Grp, Barcelona 08036, Catalonia, Spain
[2] Univ Barcelona, ICMSN, IDIBAPS, Hosp Clin,Memory Alzheimer Unit, Barcelona 08036, Catalonia, Spain
[3] IRO, Med & Mol Genet Ctr, Barcelona, Spain
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2003年 / 206卷 / 01期
关键词：
mitochondria; electron transport chain; respiratory chain; rivastigmine; neurodegenerative disorders; dementia;
D O I：
10.1016/S0022-510X(02)00319-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Electron transport chain (ETC) dysfunction has been claimed to contribute to the expression of neurodegenerative disorders. We have investigated the effects of the treatment with rivastigmine, a commonly used cholinesterase inhibitor, on lymphocyte mitochondria of patients with Alzheimer's disease (AD). Increased enzymatic activities of diverse complexes and oxidative capacity of the ETC were found. Enhanced mitochondrial ETC function may contribute to the beneficial effects of rivastigmine on clinical manifestations of AD. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码：23 / 26
页数：4
相关论文
共 50 条
  • [31] Efficacy and Safety of Switching from Oral Cholinesterase Inhibitors to the Rivastigmine Transdermal Patch in Patients with Probable Alzheimer's Disease
    Han, Hyun Jeong
    Lee, Jeong Ju
    Park, Sun A.
    Park, Hyun Young
    Kim, Jeong Eun
    Shim, Young Soo
    Shim, Dong-Seok
    Kim, Eun-Joo
    Yoon, Soo Jin
    Choi, Seong Hye
    JOURNAL OF CLINICAL NEUROLOGY, 2011, 7 (03): : 137 - 142
  • [32] Bisphenol B: An inhibitor of mitochondrial electron transport chain protein
    Gupta, Shivani
    Pinjari, Dastagiri
    Yadav, Deepak
    Kumar, Deepak
    Bhattacharyya, Rajasri
    Banerjee, Dibyajyoti
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 2025, 62 (04): : 426 - 430
  • [33] Pharmacokinetics of rivastigmine and its metabolite in patients with Alzheimer's disease
    Cutler, NR
    Hossain, M
    McDonald, C
    Pommier, F
    Sedek, G
    Jhee, SS
    Sramek, JJ
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 161S - 161S
  • [34] Predictors of Sustained Response to Rivastigmine in Patients with Alzheimer's Disease
    Sadowsky, Carl
    Grossberg, George T.
    Somogyi, Monique
    Meng, Xiangyi
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2011, 19 (03): : S120 - S121
  • [35] Effects of Rivastigmine in Alzheimer's Disease Patients with and Without Hallucinations
    Cummings, Jeffrey
    Emre, Murat
    Aarsland, Dag
    Tekin, Sibel
    Dronamraju, Nalina
    Lane, Roger
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (01) : 301 - 311
  • [36] Lack of significant drug-drug interactions with aceylcholonesterase inhibitor rivastigmine in Alzheimer's Disease patients
    Grossberg, GT
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S63 - S63
  • [37] Efficacy of rivastigmine on loss of appetite in patients with Alzheimer's disease
    Tsuno, N.
    Mori, T.
    Nakamura, Y.
    EUROPEAN PSYCHIATRY, 2017, 41 : S176 - S177
  • [38] Electron transport chain enzymes in the superior temporal gyrus in Alzheimer's disease
    Higgins, DS
    Greenamyre, JT
    BRAIN PATHOLOGY, 1996, 6 (03) : 352 - 352
  • [39] Mitochondrial electron transport chain complexes in aging rat brain and lymphocytes
    Sukhjit Kaur Sandhu
    Gurcharan Kaur
    Biogerontology, 2003, 4 : 19 - 29
  • [40] Mitochondrial electron transport chain complexes in aging rat brain and lymphocytes
    Sandhu, SK
    Kaur, G
    BIOGERONTOLOGY, 2003, 4 (01) : 19 - 29
12345